Form 4: Scholar Rock Holding Corp Director Sells Shares Under 10b5-1 Plan

Srinivas Akkaraju, a director of Scholar Rock Holding Corp, reports the sale of common stock held indirectly through Samsara BioCapital, L.P., under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Srinivas Akkaraju, a director of Scholar Rock Holding Corp, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates sales of common stock on October 7, 2024, at prices of $27.50, $30.00, and $32.50.
• A total of 1,175,713 shares were sold indirectly through Samsara BioCapital, L.P.
• Akkaraju disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
• The sales were executed under a Rule 10b5-1 trading plan adopted on June 10, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. There's no inherent positive or negative implication.

Risks

• The sale of a significant number of shares by a director could be perceived negatively by the market.

Management Comments

• The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Industry Context

Sales by insiders are a common occurrence, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on inside information. The market reaction will depend on the size of the sale relative to the company's float and the overall market sentiment.

Stakeholder Impact

• The sale of shares could have a minor negative impact on shareholder sentiment in the short term.

Key Dates